New Zealand Clinical Research (NZCR) was formed through the merging of New Zealand’s two world leading, early phase clinical research organisations, Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST). The organisation is a leading provider of clinical research services with extensive experience conducting early phase clinical trials for global pharmaceutical and biotechnology companies.
The clinical research sector is supported by favourable industry trends including growth in global healthcare and medicines expenditure and growing investment by pharmaceutical and biotechnology companies in research and development activities.
Waterman was attracted to NZCRs outstanding global reputation and the potential to further develop New Zealand’s clinical research infrastructure.
Contact: Matt Riley
New Zealand Clinical Research (NZCR) was formed through the merging of New Zealand’s two world leading, early phase clinical research organisations, Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST). The organisation is a leading provider of clinical research services with extensive experience conducting early phase clinical trials for global pharmaceutical and biotechnology companies.
The clinical research sector is supported by favourable industry trends including growth in global healthcare and medicines expenditure and growing investment by pharmaceutical and biotechnology companies in research and development activities.
Waterman was attracted to NZCRs outstanding global reputation and the potential to further develop New Zealand’s clinical research infrastructure.
